Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes.
about
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementThe Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsSerum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 DiabetesSingle-donor islet transplantation in type 1 diabetes: patient selection and special considerations.Presence of diabetes autoantigens in extracellular vesicles derived from human islets.Murine animal models for preclinical islet transplantation: No model fits all (research purposes).Preexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesIslet transplantation from a nationally funded UK centre reaches socially deprived groups and improves metabolic outcomes.G-CSF and Exenatide Might Be Associated with Increased Long-Term Survival of Allogeneic Pancreatic Islet Grafts.Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational StudyImmune antibody monitoring predicts outcome in islet transplantation.Autologous pancreatic islet transplantation in human bone marrow.Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago.Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Immune monitoring of islet and pancreas transplant recipients.Homeostatic T cell proliferation after islet transplantation.Monitoring Inflammation, Humoral and Cell-mediated Immunity in Pancreas and Islet Transplants.Islet Autoantibodies.Immunological Issues After Stem Cell-Based β Cell Replacement.mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes.Gene expression signature predicts human islet integrity and transplant functionality in diabetic mice.Liver perfusion changes occurring during pancreatic islet engraftment: a dynamic contrast-enhanced magnetic resonance study.Alloimmune Monitoring After Islet Transplantation: A Prospective Multicenter Assessment of 25 Recipients.Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection.Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients.Development of Autoimmune-Mediated β Cell Failure After Total Pancreatectomy With Autologous Islet Transplantation.Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function.Re-exposure to beta cell autoantigens in pancreatic allograft recipients with preexisting beta cell autoantibodies.Therapeutic Strategies for Modulating the Extracellular Matrix to Improve Pancreatic Islet Function and Survival After Transplantation.The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and SolutionsBiomarkers in Islet Cell Transplantation for Type 1 Diabetes
P2860
Q26769878-025511C5-94B8-4945-B5F3-0E4D12C83DDBQ26774993-A87BDCE7-0282-4113-B155-4C22893798EBQ28552483-6F3058A6-400D-4AD8-BD61-3C900D2C6AF1Q30252993-B2715326-12BB-486B-96CB-900706F9FB51Q33890308-311FCD38-9E5E-4904-BBF8-6A5A680B2CC7Q34375570-B328055A-E8D5-4308-B14F-4F3F490911A9Q35207904-3F2C518A-9405-4A68-9650-374749533F2BQ35558403-5854CE93-10C7-449A-8113-1FD5E5BCA77CQ36048248-7B131218-4567-4829-88FC-9B098BF281E9Q36182971-6C82714D-532F-4B3B-AF2F-3C94861823B3Q36796105-44E80C9B-F493-4229-A4B7-7DFC58F640F2Q37193323-9747EC67-911D-401A-8C27-659DAB9CE3DAQ37346582-B320426D-454E-465D-8A12-4D787BF3C85BQ37528715-A5762476-CB65-49A2-9CC5-F991D6A3F4E0Q38128768-F51E73F4-B3A2-48A9-8E6F-DCAD823F2853Q38130933-32332612-64DB-45C7-873C-BF4E24BCBFC8Q38380235-40281CF4-B03D-4D36-83AB-FC84B16B11FDQ38817211-91566172-35A2-48C9-8356-32283D1ABB20Q39446999-5F45C3BC-2C95-4A6A-97FB-0C94A7512527Q39642946-11FDEE6E-9F2A-44C6-9159-D652FED03920Q41530090-7CFEA390-BD79-48C0-B67D-E0143AB16F36Q42368940-8E4DBD6A-9715-4627-B3BE-D11210DBF297Q44522147-C8AF70B8-E654-40A0-9DB5-577CD07F3074Q47770105-D1D6C731-B90E-4165-906F-4A00E96C9770Q50088087-991367D6-DAAF-474A-8C60-D6B5416295C0Q50663436-20A0312E-FD3C-46CD-A3C4-9ECB86F0AA68Q51045685-656B56BD-4176-41CD-9C05-470EB642BE1BQ51682057-7A5187A8-E0FF-45D6-AA51-A5DFC538C440Q52923274-F76BABF0-FAF8-4081-A92F-FA0F881AA328Q55086229-73A406FA-8520-4F5A-822F-DAF47429F94AQ57821796-3452CE90-B084-4421-AEEF-764A41FB6218Q58763032-C7E791AF-CBCD-4485-8334-05C9FBA52426
P2860
Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Alloantibody and autoantibody ...... come in human type 1 diabetes.
@en
type
label
Alloantibody and autoantibody ...... come in human type 1 diabetes.
@en
prefLabel
Alloantibody and autoantibody ...... come in human type 1 diabetes.
@en
P2093
P2860
P50
P356
P1433
P1476
Alloantibody and autoantibody ...... come in human type 1 diabetes.
@en
P2093
Alejandro Espadas de Arias
Alessia Mercalli
Antonio Secchi
Emanuele Bosi
Ezio Bonifacio
Francesca Poli
Mario Scalamogna
Massimo Cardillo
Matthew J Everly
Paola Maffi
P2860
P304
P356
10.2337/DB12-1258
P407
P577
2012-12-28T00:00:00Z